Amrize (AMRZ.SW) Stock Price

Amrize Price

CLOSED
38.21
​
Market closed

Revenue at Amrize has contracted by 3.4% per year over the past 3 years to 9.23 B USD. Earnings per share have declined at 4.7% per year over the last 3 years. For Amrize, the net margin of 10.4% is broadly stable versus 10.8% a few years ago. The consensus 12-month price target for Amrize is 59.63 USD, about 56.1% above where the stock trades today. Of 18 analysts, 12 rate the stock a buy — an overall Buy consensus.

Amrize stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amrize business model & stock analysis

Amrize Ltd. engages in selling building materials. The company is headquartered in Zug, Zug. The company went IPO on 2025-06-23. The firm serves customers across infrastructure, commercial and residential markets and from new build to repair and refurbishment in North America. With over 1,000 sites and a distribution network, it delivers for customers in every U.S. state and Canadian province. Its two businesses, Building Materials and Building Envelope, offer advanced branded solutions to cover construction needs from foundation to rooftop. Its Building Materials business includes cement, concrete, aggregates, and asphalt. Its cement brands include OneCem, ECOPlanet Cements, and MaxCem. Its concrete brands include ECOPact, DYNAMax, and Ductal. Its Building Envelope business includes commercial roofing, residential roofing, weatherization, adhesives and sealants, and insulation. Its commercial roofing brands are Elevate, Duro-Last, GenFlex, and Gaco. Its insulation brands include Enverge, OX Engineered Products, and others.

Frequently asked questions about Amrize

Analysts currently set an average price target of 58.49 USD for the Amrize stock (median: 59.63 USD), implying +53.1 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the Amrize stock: 12 recommend buying, 6 holding and 0 selling. For 2026, analysts expect Amrize to generate revenue of 10.17 B USD and earnings per share of 2.39 USD.

Converted at the current exchange rate, the Amrize share trades at 34.06 EUR (38.21 USD).

The expected revenue of Amrize is 10.17 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Amrize is 1.32 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Amrize is currently 15.98. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Amrize stock.

The price-to-sales ratio (P/S) of Amrize is currently 2.08. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Amrize stock.

The Eulerpool Quality Score for Amrize is 2/10.

The ISIN of Amrize is CH1430134226. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Amrize is AMRZ.SW. The ticker symbol is used to trade Amrize shares on the stock exchange.

Fair ValueTerminal
37.44 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Construction Materials
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website amrize.com
Currency
USD
Initial public offering
Jun 23, 2025
ISIN
CH1430134226
Cusip
H2927K103
Market capitalization
21.15 B USDLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
15.99
P/Ee 2027
12.63
P/S
P/Se
2.08
EV/EBIT
15.29
P/B Ratio
1.97
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.51 %
Last updated Oct 20, 2026, 4:06 PM

Amrize Peer Group

All fundamentals and in-depth analysis of Amrize

Our stock analysis for Amrize stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amrize. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.